來源：市場資訊

（來源：歐林生物）

2026年4月23日上午，重慶市沙坪壩區(qū)人民政府副區(qū)長王晶一行蒞臨成都歐林生物科技股份有限公司（以下簡稱歐林生物，股票代碼：688319）調(diào)研，區(qū)政府辦公室副主任向錦揚、區(qū)經(jīng)濟和信息化委員會（招商中心）副主任徐琳、區(qū)衛(wèi)生健康委員會副主任奚秀麗陪同調(diào)研；歐林生物董事長、總經(jīng)理樊紹文率副總經(jīng)理兼財務(wù)負責人譚勇、副總經(jīng)理兼董事會秘書吳畏、總經(jīng)理助理馬恒軍等人接待。本次調(diào)研通過實地考察、座談交流，圍繞產(chǎn)業(yè)發(fā)展與深化合作進行了深入探討。

研）

調(diào)研中，王晶一行聽取了歐林生物關(guān)于企業(yè)發(fā)展歷程、研發(fā)創(chuàng)新、核心產(chǎn)品布局及生產(chǎn)運營情況的匯報，詳細了解企業(yè)技術(shù)優(yōu)勢、產(chǎn)業(yè)規(guī)劃和未來發(fā)展方向。

一行參觀歐林生物企業(yè)展廳）

座談會上，樊紹文對沙坪壩區(qū)委、區(qū)政府長期以來的關(guān)心支持表示感謝，并就企業(yè)發(fā)展、項目合作等與調(diào)研組深入交流；王晶對歐林生物在生物醫(yī)藥領(lǐng)域取得的成績予以充分肯定，指出沙坪壩區(qū)高度重視生物醫(yī)藥產(chǎn)業(yè)發(fā)展，將持續(xù)優(yōu)化營商環(huán)境、強化政策扶持與精準服務(wù)，全力支持企業(yè)在沙區(qū)發(fā)展，推動區(qū)域生物醫(yī)藥產(chǎn)業(yè)集群化、高端化發(fā)展。雙方圍繞產(chǎn)業(yè)合作、項目落地、公共衛(wèi)生服務(wù)等深入交流，達成廣泛共識。

隨后，王晶一行實地參觀流感疫苗生產(chǎn)車間，詳細了解疫苗生產(chǎn)工藝流程、質(zhì)量管控體系及智能化生產(chǎn)建設(shè)情況，對企業(yè)高標準、規(guī)范化的生產(chǎn)運營模式予以高度認可。

此次調(diào)研進一步密切了政企溝通，夯實了合作基礎(chǔ)。下一步，政企雙方將強化協(xié)同聯(lián)動、深化對接落實，推動更多優(yōu)質(zhì)項目落地見效。歐林生物將持續(xù)聚焦生物醫(yī)藥創(chuàng)新與產(chǎn)業(yè)升級，加快推進重點項目落地，不斷提升核心競爭力與產(chǎn)業(yè)貢獻度，以實際行動助力生物醫(yī)藥產(chǎn)業(yè)高質(zhì)量發(fā)展，為公共衛(wèi)生健康事業(yè)建設(shè)作出積極貢獻。

Short News Release:Vice District Mayor Wang Jing of Shapingba District, Chongqing Visits Olymvax

On the morning of April 23, 2026, Wang Jing, Vice District Mayor of Shapingba District, Chongqing, led a delegation to inspect Chengdu Olymvax Biopharmaceuticals Co., Ltd. (hereinafter referred to as “Olymvax”, Stock Code: 688319). The delegation was briefed on the company’s R&D progress, product portfolio and operations, and visited its influenza vaccine production workshop. At the symposium, Fan Shaowen, Chairman and General Manager of Olymvax, expressed gratitude to Shapingba District for its long-term support. Vice District Mayor Wang highly recognized Olymvax’s achievements and pledged continued policy support and an improved business environment to boost industrial clustering and upgrading.Both sides reached broad consensus on industrial cooperation, project implementation and public health services. This visit strengthened government-enterprise ties and laid a solid foundation for further collaboration. Olymvax will continue to pursue innovation and drive the high-quality development of the biopharmaceutical industry.

(Photo: Vice District Mayor Wang Jing and her delegation visit the vaccine production workshop)